IMMUNOLOGICAL TESTS
| A = Type | B = Category | C = Test | D = Result | E = Unit |
| F = Alteration | G = Expected Value | H = Date | I = Place |
| A | B | C | D | E | F | G | H | I |
| FEC | IMM | Escherichia Coli | Positive | A | 2/3/91 | Lido VE | ||
| BLO | IMM | gamma globulin | 2/4/91 | Lido VE | ||||
| BLO | IMM | A/G | 1.77 | 2/4/91 | Lido VE | |||
| BLO | IMM | albumin | 63.8 % 4.72 | g/dl | 2/4/91 | Lido VE | ||
| BLO | IMM | alfa 1 G | 3.1% 0.23 | g/dl | 2-4% | 2/4/91 | Lido VE | |
| BLO | IMM | alfa2 G | 8.6% 0.64 | g/dl | 6-10% | 2/4/91 | Lido VE | |
| BLO | IMM | beta G | 12.1% 0.9 | g/dl | 7.5-12% | 2/4/91 | Lido VE | |
| BLO | IMM | gamma G | 12.2% 0.9 | g/dl | A | 13-19% | 2/4/91 | Lido VE |
| BLO | IMM | C reactive protein | negative | 2/11/91 | Lido VE | |||
| BLO | IMM | immunoglobulins | 2/12/91 | Lido VE | ||||
| BLO | IMM | IgG | 700 | mg%ml | 800-1800 | 2/12/91 | Lido VE | |
| BLO | IMM | IgA | 25 | mg%ml | 100-400 | 2/12/91 | Lido VE | |
| BLO | IMM | IgM | 25 | mg%ml | 60-250 | 2/12/91 | Lido VE | |
| BLO | IMM | serodiagnosis Vidal-Wright | negative | 2/12/91 | Lido VE | |||
| BLO | IMM | Alpha fetoprotein | 305 | U.I.ml | ? | 2/12/91 | Lido VE | |
| BLO | IMM | alpha fetoprotein | 616.3 | ng/ml | ? | 2/14/91 | Padua | |
| URIN | IMM | esame colturale urine | negative | 2/26/91 | Verona | |||
| BLO | IMM | Immunoglobuline A | 1.5 | mg/dL | A | 20-70 | 2/26/91 | Verona |
| BLO | IMM | Immunoglobuline M | 27 | mg/dL | A | 60-210 | 2/26/91 | Verona |
| BLO | IMM | immunoglobuline G | 444 | mg/dL | 300-1090 | 2/26/91 | Verona | |
| BLO | IMM | hemoculture | Serratia liquefaciens++++ | A | 2/27/91 | Verona | ||
| BLO | IMM | search of culture Cytomegalovirus | negative | 2/27/91 | Verona | |||
| U | IMM | search of culture Cytomegalovirus | negative | 2/27/91 | Verona | |||
| FECI | IMM | culture test in aerobiosis | Escherichia Coli +++ | A | 2/28/91 | Verona | ||
| FAR | IMM | cultural pharyngeal tampon test | Neisseria sp+ | A | 3/4/91 | Verona | ||
| FAR | IMM | cultural pharyngeal tampon test | Streptococcus Alfa+++ | A | 3/4/91 | Verona | ||
| NAS | IMM | microb nasal tampon test | Staffilococcus | epider.++ | A | 3/4/91 | Verona | |
| LIQ | IMM | antibiotic residue activity | scarceness | 3/11/91 | Verona | |||
| LIQ | IMM | anaerobiosis culture | scarceness | 3/11/91 | Verona | |||
| LIQ | IMM | anaerobiosis culture | no develop. | 3/11/91 | Verona | |||
| LIQ | IMM | yeast culture | no develop. | 3/11/91 | Verona | |||
| LIQ | IMM | microscopic test | scarceness | 3/11/91 | Verona | |||
| BLO | IMM | antibodies. anti Herpes Vir. EIA IgGspec. | negative | 3/12/91 | Verona | |||
| BLO | IMM | antibodies anti Herpes Vir EIA IgM spec | negative | 3/12/91 | Verona | |||
| BLO | IMM | antibodies anti Varicella ZV EIA IgG spec | negative | 3/12/91 | Verona | |||
| BLO | IMM | antibodies anti Varicella ZV EIAIgM spec | negative | 3/12/91 | Verona | |||
| BLO | IMM | Antibodies antiPMN | negative | 03/13/91 | Verona | |||
| BLO | IMM | Antibodies.antiCMV EIA IgM spec. | negative | 03/14/91 | Verona | |||
| BLO | IMM | Antibodies.antiHerpesV EIA IgG spec. | weak.positive | 03/14/91 | Verona | |||
| BLO | IMM | Antibodies.antiHerpesV EIA IgM spec. | negative | 03/14/91 | Verona | |||
| BLO | IMM | Rubella inhibition emoaggl. | negative | 03/14/91 | Verona | |||
| BLO | IMM | Rubella EIA IgG spec. | weak.positive | 03/14/91 | Verona | |||
| BLO | IMM | Rubella EIA IgM spec. | negative | 03/14/91 | Verona | |||
| BLO | IMM | Toxoplasmosis EIA IgG spec. | weak. positive | 03/14/91 | Verona | |||
| BLO | IMM | Toxoplasmosis EIA IgM spec. | negative | 03/14/91 | Verona | |||
| BLO | IMM | Toxoplasmosis emoaggl. ind. | 03/14/91 | Verona | ||||
| LIQ | IMM | search of Antib.against NEUROTR | 03/15/91 | Verona | ||||
| LIQ | IMM | Coxsackia B4-B5-B6 | scarceness | 03/15/91 | Verona | |||
| LIQ | IMM | Coxsackie B1-B2-B3 | negative | 03/15/91 | Verona | |||
| LIQ | IMM | Cytomegalovirus | negative | 03/15/91 | Verona | |||
| LIQ | IMM | Enterovirus mix | negative | 03/15/91 | Verona | |||
| LIQ | IMM | HSV1-HSV2 | scarceness | 03/15/91 | Verona | |||
| LIQ | IMM | Virus measles | negative | 03/15/91 | Verona | |||
| LIQ | IMM | Virus parotitis | negative | 03/15/91 | Verona | |||
| LIQ | IMM | Virus V-Z | negative | 03/15/91 | Verona | |||
| BLO | IMM | Antibodies anti virus influenza A | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti virus influenza B | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti virus parainfluenza 1 | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti virus parainfluenza 2 | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti virus parainfluenza 3 | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti Adenovirus | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti ECHO virus neurotropi | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti Morbillivirus | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti Cytomegalovirus | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti Varicella Zoster virus | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti virus parotite | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti Poliovirus | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti Herpes Simplex virus | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies antiCoxsackievirus A | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti Coxsackievirus B | inferior 1:10 | 4/5/91 | Padua | |||
| BLO | IMM | Antibodies anti Epstein Barr virus | 4/5/91 | Padua | ||||
| BLO | IMM | IgM anti VCA | negative | 4/5/91 | Padua | |||
| BLO | IMM | IgG anti VCA | positive 1:64 | A | 4/5/91 | Padua | ||
| BLO | IMM | IgG anti EA | positive | A | 4/5/91 | Padua | ||
| BLO | IMM | IgG anti EBNA | positive | A | 4/5/91 | Padua | ||
| BLO | IMM | Alfa fetoprotein | 45 | A | 07/19/91 | Bologna | ||
| LIQ | IMM | total proteins | 0.24 | g/L | 0-0.50 | 02/17/93 | Padua | |
| LIQ | IMM | microscopic test | leucocyte absent.no microorganismi | 02/17/93 | Padua | |||
| LIQ | IMM | cultural test | no develop | 02/17/93 | Padua | |||
| LIQ | IMM | search of acid-alcohol-fast bacterium | negativa | 02/17/93 | Padua | |||
| LIQ | IMM | search of bacteria agent | negative | 02/17/93 | Padua | |||
| LIQ | IMM | mycobacterium cultural test | negative | 02/17/93 | Padua | |||
| BLO | IMM | albumin zone | 29 | g/L | A | 35-55 | 3/1/93 | Padua |
| BLO | IMM | zone Alfa 1 | 3.29 | g/L | A | 1.2-3.2 | 3/1/93 | Padua |
| BLO | IMM | zone Alfa 2 | 9.13 | g/L | 4.2-9.2 | 3/1/93 | Padua | |
| BLO | IMM | zone Beta 1 | 4.43 | g/L | 3\9 | 3/1/93 | Padua | |
| BLO | IMM | zone Beta 2 | 2.27 | g/L | 1.2-4.5 | 3/1/93 | Padua | |
| BLO | IMM | zone Gamma | 5.83 | g/L | A | 7.1-16 | 3/1/93 | Padua |
| BLO | IMM | component Ciq | 170 | mg/l | 100-250 | 3/2/93 | Padua | |
| BLO | IMM | C1 Esterase inhibitor | 610 | mg/l | A | 174-240 | 3/2/93 | Padua |
| BLO | IMM | component C3 | 0.78 | g7l | 0.55-1.2 | 3/2/93 | Padua | |
| BLO | IMM | component C4 | 0.33 | g/l | 0.15-0.5 | 3/2/93 | Padua | |
| BLO | IMM | C3 activator | 218 | mg7l | 200-450 | 3/2/93 | Padua | |
| BLO | IMM | IgG | 8.21 | g/L | 8\17 | 3/2/93 | Padua | |
| BLO | IMM | IgA | 1.8 | g/l | 0.85-4.9 | 3/2/93 | Padua | |
| BLO | IMM | IgM | 2.99 | g/l | A | 0.5-2.8 | 3/2/93 | Padua |
| BLO | IMM | AUTOantibodies ORGAN SPECIFIC | 3/3/93 | Padua | ||||
| BLO | IMM | Anti thyroid thyroglobulin (EAP) | negative | 3/3/93 | Padua | |||
| BLO | IMM | Anti thyroid microsome (EAP) | negative | 3/3/93 | Padua | |||
| BLO | IMM | Antistomach parietal cell (IFI) | negative | 3/3/93 | Padua | |||
| BLO | IMM | Anti adrenal gland cortical | negative | 3/3/93 | Padua | |||
| BLO | IMM | Anti medullar adrenal gland | negative | 3/3/93 | Padua | |||
| BLO | IMM | Anti pancreatic insula | negative | 3/3/93 | Padua | |||
| BLO | IMM | AUTOantibodies NOT ORGAN SPECIFIC | 3/3/93 | Padua | ||||
| BLO | IMM | Anti mitochondrion | negative | 3/3/93 | Padua | |||
| BLO | IMM | Anti ribosome | negative | 3/3/93 | Padua | |||
| BLO | IMM | Anti smooth muscle | negative | 3/3/93 | Padua | |||
| BLO | IMM | Electrophoresis Proteica | 5/11/94 | Mestre | ||||
| BLO | IMM | A/G | 2.17 | 5/11/94 | Mestre | |||
| BLO | IMM | albumin | 68.5 | % | A | 55-68 | 5/11/94 | Mestre |
| BLO | IMM | Alfa 1 globulin | 3.4 | % | 2\5 | 5/11/94 | Mestre | |
| BLO | IMM | Alfa 2 globulin | 8.5 | % | 7\11 | 5/11/94 | Mestre | |
| BLO | IMM | Beta globulin | 8.3 | % | 8\13 | 5/11/94 | Mestre | |
| BLO | IMM | gamma G | 11.3 | % | A | 13-19 | 5/11/94 | Mestre |
| BLO | IMM | IgG | 868 | mg/dl | 800-1800 | 5/11/94 | Mestre | |
| BLO | IMM | IgA | 89.2 | mg/dl | 90-450 | 5/11/94 | Mestre | |
| BLO | IMM | IgM | 180 | mg/dl | 60-250 | 5/11/94 | Mestre | |
| BLO | IMM | alb/glob ratio | 2.06 | % | 1.2-2.1 | 09/22/94 | Mestre | |
| BLO | IMM | Alpha 1 globulin | 3.4 | % | 2\5 | 09/22/94 | Mestre | |
| BLO | IMM | Alpha 2 globulin | 8.6 | % | 7\11 | 09/22/94 | Mestre | |
| BLO | IMM | Beta globulin | 9.5 | % | 8\13 | 09/22/94 | Mestre | |
| BLO | IMM | gamma globulin | 11.2 | % | A | 13-19 | 09/22/94 | Mestre |
| BLO | IMM | dosage C3 | 53 | mg/dl | A | 55-90 | 09/22/94 | Mestre |
| BLO | IMM | dosage C4 | 19 | mg/dl | 10\40 | 09/22/94 | Mestre | |
| BLO | IMM | IgA | 104 | mg/dl | 90-450 | 09/22/94 | Mestre | |
| BLO | IMM | IgM | 173 | mg/dl | 70-280 | 09/22/94 | Mestre | |
| BLO | IMM | total I.g.E | 63 | IU/ml | A | 0-34 | 09/22/94 | Mestre |
| BLO | IMM | I.g.E specific : couch-grass pratense | min.0.35 | ku/l | 0-34 | 09/22/94 | Mestre | |
| BLO | IMM | I.g.E specific :Alternaria Alternata | 0.47 | A | 0-34 | 09/22/94 | Mestre | |
| BLO | IMM | immunoglobulins | 11/29/94 | Verona | ||||
| BLO | IMM | IgA | 1.05 | g/l | 11/29/94 | Verona | ||
| BLO | IMM | IgG | 8.12 | g/l | 11/29/94 | Verona | ||
| BLO | IMM | IgM | 1.6 | g/l | 11/29/94 | Verona | ||
| BLO | IMM | IgE | 57 | kU/l | 11/29/94 | Verona | ||
| BLO | IMM | IgG subclass | 11/29/94 | Verona | ||||
| BLO | IMM | G1 | 4130 | mg/L | 11/29/94 | Verona | ||
| BLO | IMM | G2 | 2890 | mg/L | 11/29/94 | Verona | ||
| BLO | IMM | G3 | 374 | mg/L | 11/29/94 | Verona | ||
| BLO | IMM | G4 | 1136 | mg/L | 11/29/94 | Verona | ||
| BLO | IMM | subpopolation lymphocyte | 11/29/94 | Verona | ||||
| BLO | IMM | total lymphocyte | 52.80% | 11/29/94 | Verona | |||
| BLO | IMM | total lymphocyte T | 52.80% | 11/29/94 | Verona | |||
| BLO | IMM | lymphocyte T Helper | 50.50% | 11/29/94 | Verona | |||
| BLO | IMM | lymphocyte T cytotoxic | 24.50% | 11/29/94 | Verona | |||
| BLO | IMM | Help/ Supp | 2.06% | 11/29/94 | Verona | |||
| BLO | IMM | total lymphocyte B | 15.50% | 11/29/94 | Verona | |||
| BLO | IMM | Lymphocyte Natural Killer | 2% | 11/29/94 | Verona | |||
| BLO | IMM | (HLA - DR)+CD3 | 16 | 11/29/94 | Verona | |||
| BLO | IMM | HLA | 11/29/94 | Verona | ||||
| BLO | IMM | HLA-A | A2-A3 | 11/29/94 | Verona | |||
| BLO | IMM | HLA-B | B7-B62(15)BW6 | 11/29/94 | Verona | |||
| BLO | IMM | HLA-C | CW1-CW7 | 11/29/94 | Verona | |||
| BLO | IMM | HLA-DR | DR1-DR11 (5)-DR52 | 11/29/94 | Verona | |||
| BLO | IMM | HLA-DQ | DQ1-DQ7 (3) | 11/29/94 | Verona | |||
| BLO | IMM | Alb/Glob | 1.49 | % | 1.2-2.1 | 02/21/95 | Mestre | |
| BLO | IMM | albumin | 59.8 | % | 55-68 | 02/21/95 | Mestre | |
| BLO | IMM | alpha 1 globulin | 5.3 | % | A | 2\5 | 02/21/95 | Mestre |
| BLO | IMM | alpha 2 globulin | 12.4 | % | 5.6-11 | 02/21/95 | Mestre | |
| BLO | IMM | Beta globulin | 11.9 | % | 8\13 | 02/21/95 | Mestre | |
| BLO | IMM | gamma globulin | 10.6 | % | A | 13-19 | 02/21/95 | Mestre |
| BLO | IMM | IgA | 171 | mg/dl | 90-450 | 02/21/95 | Mestre | |
| BLO | IMM | IgG | 1240 | mg/dl | 800-1800 | 02/21/95 | Mestre | |
| BLO | IMM | IgM | 241 | mg/dl | 60-250 | 02/21/95 | Mestre | |
| FE | IMM | coproculture. Candida A. | many colonies | A | 03/30/95 | Mestre | ||
| BLO | IMM | antibodies anti DNA | absent | 7/6/95 | Treviso | |||
| BLO | IMM | antibodies Anti endomysium | negative | 7/6/95 | Treviso | |||
| BLO | IMM | antibodies Anti gliadin | negative | 7/6/95 | Treviso | |||
| BLO | IMM | antibodies Anti mitochondrion | absent | 7/6/95 | Treviso | |||
| BLO | IMM | antibodies Anti smooth muscle | absent | 7/6/95 | Treviso | |||
| BLO | IMM | antibodies Anti nucleus | absent | 7/6/95 | Treviso | |||
| BLO | IMM | antibodies Anti thyroid | absent | 7/6/95 | Treviso | |||
| BLO | IMM | dosageC3 | 87 | 7/6/95 | Treviso | |||
| BLO | IMM | dosageC4 | 82 | 7/6/95 | Treviso | |||
| BLO | IMM | antibodies anti cerebellum | negative | 12/7/95 | Padua | |||
| BLO | IMM | antibodies anti cerebrum | negative | 12/7/95 | Padua | |||
| BLO | IMM | immunoglobulins | 4/4/96 | Padua | ||||
| BLO | IMM | IgG | 13.1 | g/L | 7.5 -15 | 4/4/96 | Padua | |
| BLO | IMM | IgA | 2.09 | g/L | A | 0 - 0.6 | 4/4/96 | Padua |
| BLO | IMM | IgM | 2.12 | g/L | A | 0 .11 -0.35 | 4/4/96 | Padua |
| BLO | IMM | subclass IgG | 4/4/96 | Padua | ||||
| BLO | IMM | IgG1 | 421 | mg/dL | 143 - 394 | 4/4/96 | Padua | |
| BLO | IMM | IgG2 | 424 | mg/dL | 23 - 147 | 4/4/96 | Padua | |
| BLO | IMM | IgG3 | 39 | mg/dL | 4 - 100 | 4/4/96 | Padua | |
| BLO | IMM | IgG4 | 216 | mg/dL | A | 1..-14 | 4/4/96 | Padua |
| BLO | IMM | lymphocyte subpopolation | 4/4/96 | Padua | ||||
| BLO | IMM | B - CD3 ( T linfoc. maturi) | 78 | % | 68 -82 | 4/4/96 | Padua | |
| BLO | IMM | B _ CD4 + CD3 (T - helper. inducer) | 41 | % | 36 -52 | 4/4/96 | Padua | |
| BLO | IMM | B - CD8 + CD3 (linfo T suppress.cytotoxic) | 22 | % | 20 - 34 | 4/4/96 | Padua | |
| BLO | IMM | CD4 / CD8 rate | 1.9 | 1.8 -2.1 | 4/4/96 | Padua | ||
| BLO | IMM | total IgE | 38 | KU/L | <80 | 4/4/96 | Padua | |
| BLO | IMM | serology bacteria infection | 4/4/96 | Padua | ||||
| BLO | IMM | IgG antiHelicobacter Pylori | <2 | U/L | fino a 21 | 4/4/96 | Padua | |
| BLO | IMM | serology virus infection | 4/4/96 | Padua | ||||
| BLO | IMM | antibodies anti : Herpes Simplex v. IgM | negative | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti : Herpes Simplex v. IgG | negative | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti V. parotite IgM | negative | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti V. parotite IgG | negative | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti EBV IgM | negative | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti EBV IgG | negative | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti Citomegalovirus | inf 1:10 | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti Herpers Simplex virus | inf 1:10 | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti virus parotite | inf 1:10 | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti Parvovirus.B19 IgG EIA | negative | 4/4/96 | Padua | |||
| BLO | IMM | antibodies anti Parvovirus.B19 IgM EIA | negative | 4/4/96 | Padua | |||
| FECI | IMM | many eggs Dipylidium Caninum | A | 04/30/96 | Rome | |||
| FECI | IMM | many pinworms | A | 04/30/96 | Rome | |||
| FECI | IMM | Oxyuris Vermicularis | Positive | A | 04/30/96 | Rome | ||
| FECI | IMM | Dypilidium Caninum | Positive | A | 04/30/96 | Rome | ||
| FECI | IMM | Candida Albicans | Many Colonies | A | 04/30/96 | Rome | ||
| FECI | IMM | Escherichia Coli | Many Colonies | A | 04/30/96 | Rome | ||
| FECI | IMM | Streptococcus Foecalis | Many Colonies | A | 04/30/96 | Rome | ||
| FECI | IMM | Staphilococcus Aureus | Many Colonies | A | 04/30/96 | Rome | ||
| FECI | IMM | Klebsiella Pneumonie | Many Colonies | A | 04/30/96 | Rome | ||
| FECI | IMM | Giardia Intestinalis | A | 09/10/96 | Rome | |||
| BLO | IMM | HBsAg | negativo | 10/1/96 | Verona | |||
| BLO | IMM | anti Hbs Ag | 0 | 10/1/96 | Verona | |||
| BLO | IMM | ANTI CORE HBV | negativo | 10/1/96 | Verona | |||
| BLO | IMM | ANTI HAV TOTALI | negativo | 10/1/96 | Verona | |||
| BLO | IMM | ANTI HAV IgM | negativo | 10/1/96 | Verona | |||
| BLO | IMM | Anti HCV (MEIA 3° Gen.) | negativo | 10/1/96 | Verona | |||
| BLO | IMM | Antibodies anti nucleo (ANA co IFA) | negativo | 10/1/96 | Verona | |||
| BLO | IMM | antibodies anti MAG | negativo | 10/1/96 | Verona | |||
| BLO | IMM | Mielina | Assoni | Endo/perinevrio | 10/1/96 | Verona | ||
| BLO | IMM | IgM 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | IgG 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | IgA 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | Kappa 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | Lambda 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | Immunoglobulins | 10/1/96 | Verona | ||||
| BLO | IMM | IgA | 1.79 | g/l | 0.50-2.30 | 10/1/96 | Verona | |
| BLO | IMM | IgG | 10.8 | g/L | 4.20-15.5 | 10/1/96 | Verona | |
| BLO | IMM | IgM | 1.72 | g/L | A | 0.20-1.50 | 10/1/96 | Verona |
| BLO | IMM | subclass IgG | 10/1/96 | Verona | ||||
| BLO | IMM | G1 | 5610 | mg/L | 10/1/96 | Verona | ||
| BLO | IMM | G2 | 4480 | mg/L | A | 10/1/96 | Verona | |
| BLO | IMM | G3 | 246 | mg/L | 10/1/96 | Verona | ||
| BLO | IMM | G4 | 3890 | mg/L | A | 10/1/96 | Verona | |
| BLO | IMM | complemento C3 | 0.94 | g/L | 10/1/96 | Verona | ||
| BLO | IMM | complemento C4 | 0.23 | g/L | 10/1/96 | Verona | ||
| BLO | IMM | CH50 | 120 | Emol/ml | 10/1/96 | Verona | ||
| BLO | IMM | LYMPHOCYTES | 10/1/96 | Verona | ||||
| BLO | IMM | Total lymphocytes cell/mm3 | 3114 | 10/1/96 | Verona | |||
| BLO | IMM | Total lymphocytes % | 53.7 | 10/1/96 | Verona | |||
| BLO | IMM | T LYMPHOCYTES CD3 + | 10/1/96 | Verona | ||||
| BLO | IMM | - cells / mm3 | 2534 | 10/1/96 | Verona | |||
| BLO | IMM | - % dei linf.T nei Linf.Totali CD3+ | 81.4 | 10/1/96 | Verona | |||
| BLO | IMM | -% doppi posit.in T:CD4+CD8+in CD3+ 18.4 | 0.5 | 10/1/96 | Verona | |||
| BLO | IMM | - % doppi negat. inT. CD4-CD8-in CD3+ | 18.4 | 10/1/96 | Verona | |||
| BLO | IMM | T 4 LYMPHOCYTES CD3+ CD4+ | 10/1/96 | Verona | ||||
| BLO | IMM | - cells / mm3 | 1304 | 10/1/96 | Verona | |||
| BLO | IMM | -% T4 Lymp. in total Lymp. CD3+CD4+ | 41.9 | 10/1/96 | Verona | |||
| BLO | IMM | -% T4 Lymp. in T Lymp. CD4+ in CD3+ | 52 | 10/1/96 | Verona | |||
| BLO | IMM | T 8 LYMPHOCYTES CD3+ CD8+ | 10/1/96 | Verona | ||||
| BLO | IMM | - cells / mm3 | 753 | 10/1/96 | Verona | |||
| BLO | IMM | -% T 8 Lymp in Total Lymp CD3+ CD8+ | 24.2 | 10/1/96 | Verona | |||
| BLO | IMM | - % T 8 Lymp.in T Lymp CD8+ in CD3+ | 29.5 | 10/1/96 | Verona | |||
| BLO | IMM | - % CD 28+ in T 8: CD28+ in CD8+ | 76 | 10/1/96 | Verona | |||
| BLO | IMM | - % CD57+ in T 8: CD57+ in CD8+ | 7 | 10/1/96 | Verona | |||
| BLO | IMM | ratio 28/57 in T 8: CD28+/CD57+ in CD8+ 10.85 | 10.85 | 10/1/96 | Verona | |||
| BLO | IMM | ratio T4/T8 | 1.73 | 10/1/96 | Verona | |||
| BLO | IMM | B LYMPHOCYTES CD19+ | 10/1/96 | Verona | ||||
| BLO | IMM | - cells / mm3 | 392 | 10/1/96 | Verona | |||
| BLO | IMM | -% B Lymp. in total Lymp. CD 19+ | 12.6 | 10/1/96 | Verona | |||
| BLO | IMM | NK LYMPHOCYTES | 10/1/96 | Verona | ||||
| BLO | IMM | - cells/ MM3 | 183 | 10/1/96 | Verona | |||
| BLO | IMM | - % NK Lymp. in Tot. Lymp | 10/1/96 | Verona | ||||
| BLO | IMM | CD16+ e/o CD56+ CD3- | 5.9 | 10/1/96 | Verona | |||
| BLO | IMM | - % T Lymp with NK activity: | 10/1/96 | Verona | ||||
| BLO | IMM | CD16+ e/o CD56 + CD3+ | 1.6 | 10/1/96 | Verona | |||
| BLO | IMM | CD18+ in CD8+ | 99.60% | 10/1/96 | Verona | |||
| BLO | IMM | CD18+ in CD4+ | 95% | 10/1/96 | Verona | |||
| BLO | IMM | CD11+ in CD8+ | 99.10% | 10/1/96 | Verona | |||
| BLO | IMM | CD11+ in CD4+ | 89.70% | 10/1/96 | Verona | |||
| BLO | IMM | CD45RO+ in CD8+ | 49% | 10/1/96 | Verona | |||
| BLO | IMM | CD45RO+ in CD4+ | 26% | 10/1/96 | Verona | |||
| BLO | IMM | CD45RA+ IN CD8+ | 87.40% | 10/1/96 | Verona | |||
| BLO | IMM | CD45RA+ in CD4+ | 75% | 10/1/96 | Verona | |||
| BLO | IMM | In vitro response to Phitoemoagglutinin | 1-13-97 | Padua | ||||
| BLO | IMM | bovine fetal serum | normal range | 1-13-97 | Padua | |||
| BLO | IMM | base | 537 | 470 +/- 301 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 10 ugr/ml | 41.483 | 141.310 +-24. | 1-13-97 | Padua | ||
| BLO | IMM | PHA 5 ugr/ml | 67.104 | 157.594+-23. | 1-13-97 | Padua | ||
| BLO | IMM | PHA 2,5 ugr/ml | 40.456 | 134.630+-10 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 1 ugr/ml | 54.045 | 50.114+-8.881 | 1-13-97 | Padua | ||
| BLO | IMM | autologus serum | 1-13-97 | Padua | ||||
| BLO | IMM | base | 405 | 870 +- 301 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 10 ugr/ml | 97.004 | 128.650+-27. | 1-13-97 | Padua | ||
| BLO | IMM | PHA 5 ugr/ml | 149.235 | 148.123+-25 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 2,5 ugr/ml | 159.235 | 128.734+-14 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 1 ugr/ml | 43.095 | 59.125 +-8 | 1-13-97 | Padua | ||
| BLO | IMM | response to ConA | 1-13-97 | Padua | ||||
| BLO | IMM | ConA 2,5 mgr/ml | 17.306 | 1-13-97 | Padua | |||
| BLO | IMM | ConA 5 mgr/ml | 68.518 | 1-13-97 | Padua | |||
| BLO | IMM | ConA 20 mgr/ml | 160.975 | 1-13-97 | Padua | |||
| BLO | IMM | response to PWM | 1-13-97 | Padua | ||||
| BLO | IMM | PWM 0,5 mgr/ml | 93.736 | 1-13-97 | Padua | |||
| BLO | IMM | PWM 1 mgr/ml | 114.151 | 1-13-97 | Padua | |||
| BLO | IMM | PWM 2 mgr/ml | 95.807 | 1-13-97 | Padua | |||
| BLO | IMM | anti CD3 | 1-13-97 | Padua | ||||
| BLO | IMM | a-CD3 20 ngr/ml | 47.466 | 1-13-97 | Padua | |||
| BLO | IMM | IMMUNOLOGICAL MARKERS | 1-13-97 | Padua | ||||
| BLO | IMM | CD3 total T lymp. | 88 | (75%+- 5) | 1-13-97 | Padua | ||
| BLO | IMM | CD4 helper | 43 | (47%+-5) | 1-13-97 | Padua | ||
| BLO | IMM | CD8 T suppressor | 29 | (28%+-6) | 1-13-97 | Padua | ||
| BLO | IMM | RATIO CD4/CD8 | 1,5 | 1.8 +-0,7 | 1-13-97 | Padua | ||
| BLO | IMM | CD19 total B lymp. | 4 | 10%+-3 | 1-13-97 | Padua | ||
| BLO | IMM | CD5 total T lymp. | 90 | 70% +-6 | 1-13-97 | Padua | ||
| BLO | IMM | CD25 | 6 | <2% | 1-13-97 | Padua | ||
| BLO | IMM | SmIg total B lymp. | 5 | 9%+- 3 | 1-13-97 | Padua | ||
| BLO | IMM | CD56 N.K. | 9 | 13% +- 5 | 1-13-97 | Padua | ||
| BLO | IMM | CD16 N.K. | 9 | 13 % +-5 | 1-13-97 | Padua | ||
| BLO | IMM | CD57 | 10 | 17% +- 4 | 1-13-97 | Padua | ||
Home Page | Anita's Story | Physiotherapist's Report | Test Results | CAT and NMR scans | E-Mail
If you experience any problems viewing this site.
drop us an e-line at oracle@rialto.com